Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Br J Haematol
; 196(2): 360-362, 2022 01.
Article
de En
| MEDLINE
| ID: mdl-34476803
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Immunoglobuline G
/
Immunothérapie adoptive
/
SARS-CoV-2
/
COVID-19
/
Vaccin BNT162
/
Anticorps antiviraux
Type d'étude:
Etiology_studies
Limites:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Br J Haematol
Année:
2022
Type de document:
Article
Pays d'affiliation:
France